Thursday, April 3, 2025
4/3/2025
ODMHSAS SOSIII - The Oklahoma Department of Mental Health and Substance Abuse Services ODMHSAS is requesting 15,795,312 for a three year State Opioid and Stimulant SOS3 initiative, to address the critical public health crisis posed by opioid and other stimulant misuse. The focus is on three priority areas: Prevention, Treatment, and Recovery Support Services. The statewide initiative targets the uninsured, underinsured, and diverse underserved individuals and their families, including Native Americans, tribal communities, persons discharged from incarceration, veterans, pregnant and post partem women, and transitioning youth. While Methamphetamine remains the greatest drug threat in Oklahoma, with the Oklahoma Bureau of Narcotics and Dangerous Drugs OBNDD reporting 729 methamphetamine-related fatal overdoses in 2022, a 22% increase from the previous year, synthetic opioids and fentanyl-laced counterfeit prescription pills have surged, contributing to 1,721 fatal overdoses in 2022. The number of overdose deaths involving fentanyl in 2022 was nearly 16 times higher than in 2018. The Oklahoma SOS3 project will implement a comprehensive continuum of prevention, harm reduction, treatment, and recovery support services, addressing concurrent substance abuse disorders. The Initiative aims to increase community knowledge to prevent opioid and stimulant abuse while enhancing access to services. It will expand community outreach through training and local action on opioid and stimulant misuse prevention. Additionally, the program seeks to enhance workforce knowledge and support for individuals at risk or with opioid use disorder (OUD), their families, and the community through training, consultation, and naloxone distribution. Promoting social and emotional health for students to reduce disruptive behavior and improve instructional time is another key focus. The initiative will also strengthen community referral networks for individuals with OUD by mobilizing regional resources and increasing access to a range of treatments for OUD and substance use disorders SUDs, including FDA-approved medications for OUD and stimulant misuse. To achieve these goals, the SOS program will collaborate closely with treatment providers and institutions serving vulnerable populations. This partnership aims to educate and empower at risk individuals and their communities by providing overdose prevention education, facilitating treatment referrals, and connecting individuals with local support networks. By aligning state and grant funding, ODMHSAS will maximize resources, avoid duplication of efforts, and extend services to more individuals and families in need.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).